- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05277324
The Effect of Wearing Facial Masks on Skin Parameters During the COVID-19 Pandemic
The global coronavirus disease pandemic (COVID-19) has led to an increased need to wear protective equipment such as wearing face masks and practicing hygiene measures such as more frequent use of antiseptics. These measures can lead to changes in the skin, the development of new inflammatory skin diseases or exacerbation of existing ones, with health professionals especially under the risk of developing these changes. Changes in facial skin due to wearing masks have been observed in a number of studies, however, part of the study was based solely on subjects' self-assessment or clinical assessment, and only a small part on objective measurements of skin parameters. Also, the impact of prolonged masks' use have not been investigated.
The aim of these study was to investigate the effects of constant, long-term use of protective masks on facial skin.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Split, Croatia, 21000
- Recruiting
- University of Split School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- young, healthy volunteers who gave written informed consent - students of health related professions who wear facial mask for at least six hours a day durnig their internship/practice in health care institutions
Exclusion Criteria:
- skin disease, skin damage on measurement sites
- use of corticosteroids, antihistamines and immunomodulators a month prior the inclusion and during the trial
- use of emollients three days prior the inclusion in the trial
- non-adherence to the trial protocol
- exposure to artificial and excessive natural UV radiation
- pregnancy and lactation
- skin cancer
- immunosuppression
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Transepidermal water loss change
Time Frame: Weekly measurements for the duration of six weeks
|
Tewameter will be used to assess skin barrier function as a measurement of the water loss (g/hm2).
|
Weekly measurements for the duration of six weeks
|
|
Stratum corneum hydration change
Time Frame: Weekly measurements for the duration of six weeks
|
Corneometer will be used to estimate skin dryness.
It is a relative measurement and uses arbitrary units (AU).
|
Weekly measurements for the duration of six weeks
|
|
Skin erythema change
Time Frame: Weekly measurements for the duration of six weeks
|
Mexameter will be used to assess erythema.
It is a relative measurement and uses arbitrary units (AU).
|
Weekly measurements for the duration of six weeks
|
|
Melanin content change
Time Frame: Weekly measurements for the duration of six weeks
|
Mexameter will be used to assess skin melanin content.
It is a relative measurement and uses arbitrary units (AU).
|
Weekly measurements for the duration of six weeks
|
|
Participants' reported facial skin changes
Time Frame: Weekly measurements for the duration of six weeks
|
Structured interview to determine if participants developed adverse events related to mask wearing (such as dryness, erythema, rash, scaling, pruritus, pain/burning, changes in texture or colour, ulcers etc.) between two measurement time-points.
|
Weekly measurements for the duration of six weeks
|
|
Sebum level changes
Time Frame: Weekly measurements for the duration of six weeks
|
Sebumeter will be used to assess sebum levels.
It is a relative measurement and uses arbitrary units (AU).
|
Weekly measurements for the duration of six weeks
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Montero-Vilchez T, Cuenca-Barrales C, Martinez-Lopez A, Molina-Leyva A, Arias-Santiago S. Skin adverse events related to personal protective equipment: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2021 Oct;35(10):1994-2006. doi: 10.1111/jdv.17436. Epub 2021 Jun 29.
- Park SR, Han J, Yeon YM, Kang NY, Kim E. Effect of face mask on skin characteristics changes during the COVID-19 pandemic. Skin Res Technol. 2021 Jul;27(4):554-559. doi: 10.1111/srt.12983. Epub 2020 Nov 20.
- Elston DM. Occupational skin disease among health care workers during the coronavirus (COVID-19) epidemic. J Am Acad Dermatol. 2020 May;82(5):1085-1086. doi: 10.1016/j.jaad.2020.03.012. Epub 2020 Mar 18. No abstract available.
- Akl J, El-Kehdy J, Salloum A, Benedetto A, Karam P. Skin disorders associated with the COVID-19 pandemic: A review. J Cosmet Dermatol. 2021 Oct;20(10):3105-3115. doi: 10.1111/jocd.14266. Epub 2021 Jul 1.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- RNA Virus Infections
- Virus Diseases
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Pneumonia, Viral
- Pneumonia
- Lung Diseases
- Disease Attributes
- COVID-19
- Inflammation
- Dermatitis
- Skin Diseases
- Facies
Other Study ID Numbers
- 2181-198-03-04-22-0010
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.